$5.34
0.11.91%
At close: Nov 11, 4:00 PM EST
$5.85
0.6111.64%
Pre-Market: 8:10 AM EST
SBC Medical Group Holdings Inc
SBCNASDAQ
SBC Medical Group rose 56.0% from $3.36 to $5.24, ahead of the S&P 500's +12.7%. Its worst day was Apr 20 (−17.1%), and its low came May 18 at $2.87.
Nov 13, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.12 beat the $0.12 estimate on $43.4M revenue (est. $46.0M).
−1.5% · S&P 500 0.0%
SBC Medical Group shares rose 9.3%, while the S&P 500 rose 0.7%.
Story events cover the past 12 months · Times ET
+9.3% · S&P 500 +0.7%
EPS of $0.14 beat the $0.12 estimate on $39.6M revenue (est. $46.1M).
+4.2% · S&P 500 −1.7%
SBC Medical Group shares fell 17.1%, while the S&P 500 fell 0.2%.
−17.1%, the year's worst day · S&P 500 −0.2%
EPS of $0.11 beat the $0.10 estimate on $43.1M revenue (est. $41.8M).
−7.7% · S&P 500 +0.8%
EPS of $0.10 missed the $0.12 estimate on $49.2M revenue (est. $45.6M).
−0.3% · S&P 500 +0.7%
SBC Medical Group closed at its highest level of the year, 69.3% above where the year started.
+2.7% · S&P 500 −1.2%
Where it ended: a close of $5.24 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 13, 2026 (EPS est. $0.12, revenue est. $49.0M).
Nothing in the past 12 months.
All SBC dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SBC and SPY from Benzinga historical bars. Not investment advice.
